Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Genome Research|April 1, 2015
Accurate typing of short tandem repeats from genome-wide sequencing data and its applicationsArkarachai Fungtammasan, Guruprasad Ananda, Suzanne E Hile, et al.
Nucleic Acids Research|November 29, 2019
Discovery of a new predominant cytosine DNA modification that is linked to gene expression in malaria parasitesElie Hammam, Guruprasad Ananda, Ameya Sinha, et al.
Biomarker Insights|February 13, 2019
Technical and Regulatory Considerations for Taking Liquid Biopsy to the Clinic: Validation of the JAX PlasmaMonitorTM AssayBridgette A Sisson, Jasmina Uvalic, Kevin Kelly, et al.
Plos Genetics|June 4, 2020
Transcriptomic stratification of late-onset Alzheimer's cases reveals novel genetic modifiers of disease pathologyNikhil Milind, Christoph Preuss, Annat Haber, et al.
G3 (Bethesda, Md.)|March 2, 2013
Mature microsatellites: mechanisms underlying dinucleotide microsatellite mutational biases in human cellsBeverly A Baptiste, Guruprasad Ananda, Noelle Strubczewski, et al.
Scientific Reports|January 23, 2020
Astrocyte Support for Oligodendrocyte Differentiation can be Conveyed via Extracellular Vesicles but Diminishes with AgeCory M Willis, Alexandra M Nicaise, Ernesto R Bongarzone, et al.
Genetics|December 30, 2018
Tissue-Specific Trans Regulation of the Mouse EpigenomeChristopher L Baker, Michael Walker, Seda Arat, et al.
The Prostate|September 10, 2024
A panel-based mutational signature of homologous recombination deficiency associates with response to PARP inhibition in metastatic castration-resistant prostate cancerDaniel Boiarsky, Alok K Tewari, Doga C Gulhan, et al.
Clinical Genitourinary Cancer|February 11, 2024
A Panel-Based Mutational Signature of Mismatch Repair Deficiency is Associated With Durable Response to Pembrolizumab in Metastatic Castration-Resistant Prostate CancerDaniel Boiarsky, Doga C Gulhan, Hunter Savignano, et al.
Molecular Diagnosis & Therapy|November 23, 2019
Mutation Yield of a Custom 212-Gene Next-Generation Sequencing Panel for Solid Tumors: Clinical Experience of the First 260 Cases Tested Using the JAX ActionSeq™ AssayPavalan Selvam, Meng-Chang Hsiao, Gregory Omerza, et al.
Pageof 4